Sponsor or institution
Clinical trials and research at iRegene Therapeutics Co., Ltd.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by iRegene Therapeutics Co., Ltd. that are recruiting, at sites in 2 countries (most in China (3), United States (1)). By phase: Phase 1 (2), Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Single NouvNeu001 (dopaminergic progenitor cells) injection for MSA-P | Phase 1 | Beijing, Beijing Municipality | Recruiting | Dec 17, 2025 |
| NouvNeu001 human dopaminergic progenitor cell injections for advanced Parkinson's disease. | Phase 1/2 | New York, New York | Recruiting | Aug 3, 2025 |
| Safety and effects of NouvNeu001 for early-onset Parkinson's Disease | Phase 1 | Wuhan, Hubei | Recruiting | Sep 23, 2024 |
| Evaluating a new treatment for Parkinson's disease using human progenitor cells | Phase 1/2 | Beijing, Beijing Municipality and 1 other locations | Recruiting | Dec 12, 2023 |
All recruiting trials (4)
-
Single NouvNeu001 (dopaminergic progenitor cells) injection for MSA-P
This Phase I trial will test whether a single injection of NouvNeu001 (human dopaminergic progenitor cells) is safe and may help people aged 30–70 with early Multiple System Atrophy, Parkinsonian subtype.
-
NouvNeu001 human dopaminergic progenitor cell injections for advanced Parkinson's disease.
We will try injecting NouvNeu001 (human dopaminergic progenitor cells) into the brain of people with advanced Parkinson's to see if it is safe, tolerable, feasible, and may improve symptoms.
-
Safety and effects of NouvNeu001 for early-onset Parkinson's Disease
This study tests if NouvNeu001 injections can safely improve symptoms for people with early-onset Parkinson's Disease.
-
Evaluating a new treatment for Parkinson's disease using human progenitor cells
This study is testing a new cell treatment for Parkinson's disease to see if it is safe and helps improve symptoms in patients.
Quick answers
How many clinical trials run by iRegene Therapeutics Co., Ltd. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (3 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.